Previous Article | Next Article 
Journal of Virology, February 2003, p. 1793-1800, Vol. 77, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.3.1793-1800.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and Budding
Ziying Han,1 Hani Boshra,2 J. Oriol Sunyer,2 Susan H. Zwiers,3 Jason Paragas,3 and Ronald N. Harty1*
Laboratory 412,1
Laboratory 413, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6049,2
Virology Division, U.S. Army Medical Research Institute for Infectious Diseases, Fort Detrick, Maryland 21702-50113
Received 14 August 2002/
Accepted 22 October 2002
The VP24 protein of Ebola virus is believed to be a secondary matrix protein and minor component of virions. In contrast, the VP40 protein of Ebola virus is the primary matrix protein and the most abundant virion component. The structure and function of VP40 have been well characterized; however, virtually nothing is known regarding the structure and function of VP24. Wild-type and mutant forms of VP24 were expressed in mammalian cells to gain a better understanding of the biochemical and functional nature of this viral protein. Results from these experiments demonstrated that (i) VP24 localizes to the plasma membrane and perinuclear region in both transfected and Ebola virus-infected cells, (ii) VP24 associates strongly with lipid membranes, (iii) VP24 does not contain N-linked sugars when expressed alone in mammalian cells, (iv) VP24 can oligomerize when expressed alone in mammalian cells, (v) progressive deletions at the N terminus of VP24 resulted in a decrease in oligomer formation and a concomitant increase in the formation of high-molecular-weight aggregates, and (vi) VP24 was present in trypsin-resistant virus like particles released into the media covering VP24-transfected cells. These data indicate that VP24 possesses structural features commonly associated with viral matrix proteins and that VP24 may have a role in virus assembly and budding.
* Corresponding author. Mailing address: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104-6049. Phone: (215) 573-4485. Fax: (215) 898-7887. E-mail:
rharty{at}vet.upenn.edu.
Journal of Virology, February 2003, p. 1793-1800, Vol. 77, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.3.1793-1800.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Swenson, D. L., Warfield, K. L., Warren, T. K., Lovejoy, C., Hassinger, J. N., Ruthel, G., Blouch, R. E., Moulton, H. M., Weller, D. D., Iversen, P. L., Bavari, S.
(2009). Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection. Antimicrob. Agents Chemother.
53: 2089-2099
[Abstract]
[Full Text]
-
Money, V. A., McPhee, H. K., Mosely, J. A., Sanderson, J. M., Yeo, R. P.
(2009). Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc. Natl. Acad. Sci. USA
106: 4441-4446
[Abstract]
[Full Text]
-
Hoenen, T., Groseth, A., Kolesnikova, L., Theriault, S., Ebihara, H., Hartlieb, B., Bamberg, S., Feldmann, H., Stroher, U., Becker, S.
(2006). Infection of Naive Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24. J. Virol.
80: 7260-7264
[Abstract]
[Full Text]
-
Johnson, R. F., McCarthy, S. E., Godlewski, P. J., Harty, R. N.
(2006). Ebola Virus VP35-VP40 Interaction Is Sufficient for Packaging 3E-5E Minigenome RNA into Virus-Like Particles.. J. Virol.
80: 5135-5144
[Abstract]
[Full Text]
-
Reid, St. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., Basler, C. F.
(2006). Ebola Virus VP24 Binds Karyopherin {alpha}1 and Blocks STAT1 Nuclear Accumulation.. J. Virol.
80: 5156-5167
[Abstract]
[Full Text]
-
Watanabe, S., Noda, T., Kawaoka, Y.
(2006). Functional mapping of the nucleoprotein of ebola virus.. J. Virol.
80: 3743-3751
[Abstract]
[Full Text]
-
Enterlein, S., Warfield, K. L., Swenson, D. L., Stein, D. A., Smith, J. L., Gamble, C. S., Kroeker, A. D., Iversen, P. L., Bavari, S., Muhlberger, E.
(2006). VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice. Antimicrob. Agents Chemother.
50: 984-993
[Abstract]
[Full Text]
-
Bamberg, S., Kolesnikova, L., Moller, P., Klenk, H.-D., Becker, S.
(2005). VP24 of Marburg Virus Influences Formation of Infectious Particles. J. Virol.
79: 13421-13433
[Abstract]
[Full Text]
-
Han, Z., Harty, R. N.
(2004). The NS3 Protein of Bluetongue Virus Exhibits Viroporin-like Properties. J. Biol. Chem.
279: 43092-43097
[Abstract]
[Full Text]
-
Licata, J. M., Johnson, R. F., Han, Z., Harty, R. N.
(2004). Contribution of Ebola Virus Glycoprotein, Nucleoprotein, and VP24 to Budding of VP40 Virus-Like Particles. J. Virol.
78: 7344-7351
[Abstract]
[Full Text]
-
Watanabe, S., Watanabe, T., Noda, T., Takada, A., Feldmann, H., Jasenosky, L. D., Kawaoka, Y.
(2004). Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics. J. Virol.
78: 999-1005
[Abstract]
[Full Text]